Skip to main content
Premium Trial:

Request an Annual Quote

N-of-One PrecisionInsights

N-of-One has launched PrecisionInsights, a new clinical interpretation solution specifically designed for small gene panels of 15-20 genes. PrecisionInsights is a concise, two-page report for each case providing the most recent clinical and scientific evidence specific to the identified genes and variants in the context of the specific cancer subtype. Key attributes of the product include one-business-day turnaround time; cost-effective pricing of $65 per report and a one-time $1,000 implementation; up-to-date scientific and clinical evidence; and the incorporation of NCCN guidelines and relevant therapies.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.